文献速递造血干细胞移植与细胞治疗

Dickkopf相关蛋白3是同种异体造血细胞移植后慢性GVHD的新型生物标志物

Dickkopf-related protein 3 is a novel biomarker for chronic GVHD after allogeneic hematopoietic cell transplantation.
PubMed 文献 · Blood Adv · 2020-01-01

研究采用多重质谱在 pooled 样本中发现慢性GVHD相关蛋白,并在186例独立验证样本中用免疫测定验证。结果发现血浆DKK3升高与慢性GVHD相关(无论有无硬化),ROC曲线下面积为0.85;DKK3高浓度患者非复发死亡率更高。

要点

  • 血浆DKK3升高与慢性GVHD相关,无论是否伴硬化,ROC曲线下面积为0.85。
  • 慢性GVHD(伴或不伴激素治疗)和患者年龄与DKK3浓度独立相关。
  • DKK3高浓度患者非复发死亡率高于低浓度患者。

核心结论

  • DKK3是慢性GVHD的新型生物标志物。
  • 需进一步研究确定DKK3在慢性GVHD发病机制中的生物学功能。

研究设计与样本

  • 发现阶段:采用多重质谱对混合样本进行蛋白质组学比较,包括新诊断硬化性慢性GVHD患者21例、新诊断非硬化性慢性GVHD患者33例和无慢性GVHD者20例。
  • 验证阶段:用免疫测定法测量单个发现样本及186例独立验证样本的蛋白浓度。

主要发现

  • 质谱发现分析鉴定出2个在硬化性GVHD中差异至少1.5倍的候选蛋白:Dickkopf相关蛋白3(DKK3)和白细胞介素-1受体辅助蛋白(IL1RAP)。
  • 对单个发现样本的免疫测定显示,DKK3(Wnt信号通路调节因子)是硬化性和非硬化性慢性GVHD的生物标志物。
  • 186例患者的验证分析证实,血浆DKK3浓度升高与慢性GVHD相关,无论是否存在硬化,DKK3浓度与慢性GVHD相关性的ROC曲线下面积为0.85。
  • 多元线性回归分析显示,慢性GVHD(伴或不伴激素治疗)和患者年龄与DKK3浓度独立相关。
  • DKK3高浓度患者的非复发死亡率高于低浓度患者。

局限性

  • 需进一步研究确定DKK3在慢性GVHD发病机制中的生物学功能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

To identify plasma biomarkers associated with fibrotic mechanisms of chronic graft-versus-host disease (GVHD), we used multiplex mass spectrometry with pooled samples for biomarker discovery in comparing proteomic profiles between patients with newly diagnosed sclerotic chronic GVHD (n = 21), those with newly diagnosed nonsclerotic chronic GVHD (n = 33), and those without chronic GVHD (n = 20). Immunoassay was used to measure protein concentrations of individual discovery samples and 186 independent verification samples. The discovery mass spectrometry analysis identified 2 candidate proteins with at least 1.5-fold difference in sclerotic GVHD: Dickkopf-related protein 3 (DKK3) and interleukin-1 receptor accessory protein (IL1RAP). Analysis of individual discovery samples by immunoassay showed that DKK3, a modulator of the Wnt signaling pathway, was a biomarker for both sclerotic and nonsclerotic chronic GVHD. Verification analysis of 186 patients confirmed that elevated plasma DKK3 concentrations were associated with chronic GVHD, regardless of the presence or absence of sclerosis, and that the area under the receiver operating characteristic curve was 0.85 for association of DKK3 concentrations with chronic GVHD. Multiple linear regression analysis showed that chronic GVHD with or without steroid treatment and patient age were independently associated with DKK3 concentrations. Patients with high DKK3 concentrations had a higher nonrelapse mortality than those with low concentrations. The lower IL1RAP concentrations in patients with sclerotic GVHD compared with other conditions in the discovery cohort were not confirmed in the verification cohort. DKK3 is a novel biomarker for chronic GVHD. Further studies are needed to determine the biological functions of DKK3 in the pathogenesis of chronic GVHD.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Inamoto Y, Martin PJ, Lee SJ, et al. Dickkopf-related protein 3 is a novel biomarker for chronic GVHD after allogeneic hematopoietic cell transplantation. Blood Adv. 2020. PMID: 32492155. doi:10.1182/bloodadvances.2020001485

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。